Search research articles
Contact Us
Filters
Showing results (201-210 of 218) with videos related to
Page
of 22
Sort By:
Blood
|
October 21, 2010
CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability
Brian J Lannutti, Sarah A Meadows, Sarah E M Herman, et al.
Indian Journal of Pediatrics
|
July 10, 2026
Organic Acidemias in India: Clinical and Molecular Spectrum
Sunita Bijarnia-Mahay, Deepti Gupta, Ratna D Puri, et al.
Human Mutation
|
January 27, 2021
A data set of variants derived from 1455 clinical and research exomes is efficient in variant prioritization for early-onset monogenic disorders in Indians
Neethukrishna Kausthubham, Anju Shukla, Neerja Gupta, et al.
Blood
|
June 5, 2010
Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals
Sarah E M Herman, Amber L Gordon, Amy J Wagner, et al.
BMC Biology
|
June 26, 2021
Dynamics of Verticillium dahliae race 1 population under managed agricultural ecosystems
Jie-Yin Chen, Dan-Dan Zhang, Jin-Qun Huang, et al.
The Indian Journal of Medical Research
|
July 21, 2022
Reporting adverse events of ChAdOx1 nCoV-19 coronavirus vaccine (Recombinant) among the vaccinated healthcare professionals: A cross-sectional survey
Sukhpal Kaur, Ajay Singh, Sushma Saini, et al.
Cureus
|
January 17, 2022
High-Dose Dexamethasone Versus Tocilizumab in Moderate to Severe COVID-19 Pneumonia: A Randomized Controlled Trial
Naveen B Naik, Goverdhan D Puri, Kamal Kajal, et al.
Cell
|
October 2, 2018
Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease
James Kinchen, Hannah H Chen, Kaushal Parikh, et al.
Blood
|
May 28, 2010
PI3K/p110{delta} is a novel therapeutic target in multiple myeloma
Hiroshi Ikeda, Teru Hideshima, Mariateresa Fulciniti, et al.
Journal of Medicinal Chemistry
|
September 24, 2016
Discovery of Orally Efficacious Phosphoinositide 3-Kinase δ Inhibitors with Improved Metabolic Stability
Leena Patel, Jayaraman Chandrasekhar, Jerry Evarts, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 218) with videos related to
Sort By:
Page
of 22
Blood
|
October 21, 2010
CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability
Brian J Lannutti, Sarah A Meadows, Sarah E M Herman, et al.
Indian Journal of Pediatrics
|
July 10, 2026
Organic Acidemias in India: Clinical and Molecular Spectrum
Sunita Bijarnia-Mahay, Deepti Gupta, Ratna D Puri, et al.
Human Mutation
|
January 27, 2021
A data set of variants derived from 1455 clinical and research exomes is efficient in variant prioritization for early-onset monogenic disorders in Indians
Neethukrishna Kausthubham, Anju Shukla, Neerja Gupta, et al.
Blood
|
June 5, 2010
Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals
Sarah E M Herman, Amber L Gordon, Amy J Wagner, et al.
BMC Biology
|
June 26, 2021
Dynamics of Verticillium dahliae race 1 population under managed agricultural ecosystems
Jie-Yin Chen, Dan-Dan Zhang, Jin-Qun Huang, et al.
The Indian Journal of Medical Research
|
July 21, 2022
Reporting adverse events of ChAdOx1 nCoV-19 coronavirus vaccine (Recombinant) among the vaccinated healthcare professionals: A cross-sectional survey
Sukhpal Kaur, Ajay Singh, Sushma Saini, et al.
Cureus
|
January 17, 2022
High-Dose Dexamethasone Versus Tocilizumab in Moderate to Severe COVID-19 Pneumonia: A Randomized Controlled Trial
Naveen B Naik, Goverdhan D Puri, Kamal Kajal, et al.
Cell
|
October 2, 2018
Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease
James Kinchen, Hannah H Chen, Kaushal Parikh, et al.
Blood
|
May 28, 2010
PI3K/p110{delta} is a novel therapeutic target in multiple myeloma
Hiroshi Ikeda, Teru Hideshima, Mariateresa Fulciniti, et al.
Journal of Medicinal Chemistry
|
September 24, 2016
Discovery of Orally Efficacious Phosphoinositide 3-Kinase δ Inhibitors with Improved Metabolic Stability
Leena Patel, Jayaraman Chandrasekhar, Jerry Evarts, et al.
Page
of 22